Pharmaceutical Industry

By David MeyerJuly 11, 2018

Biogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution
By Sy MukherjeeJuly 6, 2018

By Brittany ShootJuly 2, 2018

By Sy MukherjeeJune 28, 2018

By Sy MukherjeeJune 27, 2018

By Sy MukherjeeJune 26, 2018

By Clifton LeafJune 15, 2018

Eli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease
By Sy MukherjeeJune 12, 2018

By Sy MukherjeeMay 30, 2018
Most Popular








